Prof Susanna Esposito | Professor
University of Milan

Prof Susanna Esposito, Professor, University of Milan

Professor Susanna Esposito is Director of the Pediatric Highly Intensive Care Unit and the Pediatric Infectious Diseases Unit at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, where she is also Chief of the outpatient clinic for travel medicine. Professor Esposito is also Chief of one of the paediatric HIV clinics in the Regione Lombardia, and an Associate Professor in paediatrics at the Department of Pathophysiology and Transplantation, Università degli Studi di Milano. 
 
Professor Esposito is currently President of the Italian Society of Pediatric Infectious Diseases; she is also a member of the steering committee on vaccines of the Italian Society of Pediatrics and the Italian Society of Allergy and Immunology and she is Chair of the WHO European Commission for Verification of measles and rubella elimination. 
 
Professor Esposito’s research has focused on respiratory tract infections, vaccines and preventive paediatrics. She has won several post-graduate awards and her research activity has led to the publication of more than 300 full-length papers with an impact factor higher than 1,200. Professor Esposito is also involved in a number of scientific editorial activities, including International Editor of the Pediatric Infectious Disease Journal, Associate Editor of BMC Infectious Diseases, Associate Editor of Human Vaccines & Immunoterapeutics, Associate Editor of Journal of Clinical Virology and Editorial Board member of PloS One. 

Appearances:



Day Three 12th October, Human @ 14:55

Plenary Discussion: Vaccines don’t protect, vaccination does

 
  • How much damage is done with the wrong information?
  • The use of vaccines or the failure to do so
  • Why make new vaccines if we have old ones that work but aren’t being used?
  • Paving the way for a framework capable of rapidly delivering reliable data on the benefits and risks of vaccines that are on the market

More panellists to be confirmed

back to speakers